BioCentury | Jun 18, 2020
Product Development

World Economic Forum creating consortium to expand COVID-19 vaccine manufacturing capacity

The World Economic Forum is leading the establishment of a consortium that will bring the capabilities of vaccine manufacturers outside the U.S. and Europe into the fight against COVID-19. The goal is to produce billions...
BioCentury | May 6, 2020
Product Development

To ensure global access to remdesivir, Gilead building coalition spanning South Asia, Europe and the UN

...University of Oxford to manufacture its ChAdOx1 nCoV-19 adenovirus vaccine candidate, as well as with Codagenix...
BioCentury | Apr 29, 2020
Product Development

India emerging as major COVID-19 vaccine manufacturer

...developed by the University of Oxford’s Jenner Institute, as well as a live-attenuated vaccine that Codagenix...
...governments to make the vaccines available at no charge. SII would distribute and sell the Codagenix...
...margin, Poonawalla said. SII has agreed to provide milestone-based funding of preclinical and clinical development, Codagenix...
BioCentury | Feb 26, 2020
Product Development

COVID-19: A growing list of new vaccines and therapies in development

...New vaccines and therapies against COVID-19 Winnie Pong, Associate Editor, Data & Analytics Johnson & Johnson Inovio Pharmaceuticals Inc. Codagenix...
BioCentury | Feb 15, 2020
Product Development

WHO mapping out COVID-19 vaccines

...for use in their planned Phase I clinical trial in the U.S.” The prospects for Codagenix...
...Codagenix develops a successful vaccine, the Serum Institute has committed to manufacture it, Coleman said. Codagenix...
...Editor WHO U.S. Food and Drug Administration (FDA) Novavax Inc. Johnson & Johnson CureVac AG Coalition for Epidemic Preparedness Innovations Moderna Therapeutics Inc. Codagenix...
BioCentury | Feb 13, 2020
Product Development

COVID-19 update: Gilead ramping up remdesivir production; Codagenix partners with vaccine giant

...with the private sector to advance those potential candidates.” Codagenix partnering with India’s Serum Institute Codagenix...
...Codagenix develops a successful vaccine, the Serum Institute has committed to manufacture it, Coleman said. Codagenix...
...is both safe and immunogenic in both primates and small animals.” Coleman said that if Codagenix...
BioCentury | Jan 31, 2020
Clinical News

A dozen vaccine programs under way as WHO declares coronavirus public health emergency

...NYSE:JNJ). Winnie Pong, Associate Editor, Data & Analytics and Steve Usdin, Washington Editor Johnson & Johnson Inovio Pharmaceuticals Inc. Codagenix...
BioCentury | Jan 30, 2020
Distillery Therapeutics

Flu vaccines as a cancer immunotherapies

...enhanced tumor suppression when combined with the anti-PD-L1 mAb. Intratumoral injection of the 2017-2018 unadjuvanted seasonal influenza vaccine...
BioCentury | Jan 27, 2020
Company News

J&J developing coronavirus vaccine, at least nine other vaccines under development

...have been announced by: Moderna Inc. (NASDAQ:MRNA); Inovio Pharmaceuticals Inc. (NASDAQ:INO); The University of Queensland; Codagenix...
BioCentury | Jan 25, 2020
Product Development

The race is on to develop therapies and vaccines for the coronavirus outbreak

...Infectious Disease Organization - International Vaccine Centre has also started developing an engineered protein-based vaccine. Codagenix...
...some of the other new technologies that are being applied to meet the 2019-nCoV challenge, Codagenix...
...market for vaccines for emerging diseases, “so funding is really important,” he added. For now, Codagenix...
Items per page:
1 - 10 of 141